FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

EA Lew

Research Profile

Disorders

Chemicals & Drugs

Procedures

Administration, Oral

Concepts & Ideas

Co-author Network

Publications

TOP 3
David C Metz; Chris E Forsmark; EA Lew; JA Starr; Elaine Soffer; Wieslaw J Bochenek; Joseph R Pisegna
Replacement of oral proton pump inhibitors with intravenous pantoprazole to effectively control gastric acid hypersecretion in patients with Zollinger-Ellison syndrome.
EA Lew; Joseph R Pisegna; JA Starr; Elaine Soffer; Chris E Forsmark; I M Modlin; John H Walsh; M Beg; Wieslaw J Bochenek; David C Metz
Intravenous pantoprazole rapidly controls gastric acid hypersecretion in patients with Zollinger-Ellison syndrome.
David C Metz; Vijaya S Pratha; P Martin; J Paul; P N Maton; EA Lew; Joseph R Pisegna
Oral and intravenous dosage forms of pantoprazole are equivalent in their ability to suppress gastric acid secretion in patients with gastroesophageal reflux disease.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of EA Lew (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2001: David C Metz; Chris E Forsmark; EA Lew; JA Starr; Elaine Soffer; Wieslaw J Bochenek; Joseph R Pisegna
Replacement of oral proton pump inhibitors with intravenous pantoprazole to effectively control gastric acid hypersecretion in patients with Zollinger-Ellison syndrome.
The American journal of gastroenterology 2001;96(12):3274-80.
2000: EA Lew; Joseph R Pisegna; JA Starr; Elaine Soffer; Chris E Forsmark; I M Modlin; John H Walsh; M Beg; Wieslaw J Bochenek; David C Metz
Intravenous pantoprazole rapidly controls gastric acid hypersecretion in patients with Zollinger-Ellison syndrome.
Gastroenterology 2000;118(4):696-704.
2000: David C Metz; Vijaya S Pratha; P Martin; J Paul; P N Maton; EA Lew; Joseph R Pisegna
Oral and intravenous dosage forms of pantoprazole are equivalent in their ability to suppress gastric acid secretion in patients with gastroesophageal reflux disease.
The American journal of gastroenterology 2000;95(3):626-33.
1999: EA Lew; Klaus J Lewin; T Zarchy; Joseph R Pisegna
Adenocarcinoma of the colon with neuroendocrine features and secretory diarrhea.
The American journal of gastroenterology 1999;94(6):1692-4.
1998: EA Lew; RC Barbuti; Thomas O G Kovacs; B Sytnic; TJ Humphries; John H Walsh
An ascending single-dose safety and tolerance study of an oral formulation of rabeprazole (E3810).
Alimentary pharmacology & therapeutics 1998;12(7):667-72.
1997: Michael A Poles; EA Lew; DT Dieterich
Diagnosis and treatment of hepatic disease in patients with HIV.
Gastroenterology clinics of North America 1997;26(2):291-321.
1997: EA Lew; Michael A Poles; DT Dieterich
Diarrheal diseases associated with HIV infection.
Gastroenterology clinics of North America 1997;26(2):259-90.
1997: DT Dieterich; Michael A Poles; EA Lew; S Martin-Munley; J Johnson; D Nix; M J Faust
Treatment of gastrointestinal cytomegalovirus infection with twice-daily foscarnet: a pilot study of safety, efficacy, and pharmacokinetics in patients with AIDS.
Antimicrobial agents and chemotherapy 1997;41(6):1226-30.
1996: Michael A Poles; DT Dieterich; E D Schwarz; Elizabeth H Weinshel; EA Lew; R Lew; J V Scholes
Liver biopsy findings in 501 patients infected with human immunodeficiency virus (HIV).
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1996;11(2):170-7.
1995: J M Orenstein; EA Lew; Michael A Poles; DT Dieterich
The endoscopic brush cytology specimen in the diagnosis of intestinal microsporidiosis.
AIDS (London, England) 1995;9(10):1199-201.
1995: EA Lew; DT Dieterich; Michael A Poles; John V Scholes
Gastrointestinal emergencies in the patient with AIDS.
Critical care clinics 1995;11(2):531-60.
1994: Michael A Poles; EA Lew; DT Dieterich
Predisposition to cytomegalovirus infection of the gastrointestinal tract.
Annals of internal medicine 1994;120(9):810; author reply 811.
1994: DT Dieterich; EA Lew; D P Kotler; Michael A Poles; J M Orenstein
Treatment with albendazole for intestinal disease due to Enterocytozoon bieneusi in patients with AIDS.
The Journal of infectious diseases 1994;169(1):178-83.
1993: DT Dieterich; Michael A Poles; EA Lew; Paul Mendez; R Murphy; A Addessi; Janet T Holbrook; K Naughton; Dorothy N Friedberg
Concurrent use of ganciclovir and foscarnet to treat cytomegalovirus infection in AIDS patients.
The Journal of infectious diseases 1993;167(5):1184-8.
1993: DT Dieterich; Michael A Poles; M Dicker; R Tepper; EA Lew
Foscarnet treatment of cytomegalovirus gastrointestinal infections in acquired immunodeficiency syndrome patients who have failed ganciclovir induction.
The American journal of gastroenterology 1993;88(4):542-8.
1992: DT Dieterich; EA Lew; D J Bacon; K I Pearlman; J V Scholes
Gastrointestinal pneumocystosis in HIV-infected patients on aerosolized pentamidine: report of five cases and literature review.
The American journal of gastroenterology 1992;87(12):1763-70.
1992: EA Lew; DT Dieterich
Severe hemorrhage caused by gastrointestinal Kaposi's syndrome in patients with the acquired immunodeficiency syndrome: treatment with endoscopic injection sclerotherapy.
The American journal of gastroenterology 1992;87(10):1471-4.